Luxeptinib

Vendor: Abmole

Type: Molecular

SKU: M10850

Explore specifications & documents
$690.00 USD
Shipping calculated at checkout.

Documents

Coa

Available in stock (500)

Request a quotation
  • Customs clearance fees may apply
  • Worldwide shipping available.
For research use only — not intended for clinical or diagnostic purposes.
Luxeptinib

Luxeptinib

$690.00 USD

THE SCIENCE, IN DETAIL

Know your product.

Specifications
Bioactivity
Luxeptinib (CG-806) is an orally active, reversible, first-in-class, non-covalent, potent pan-FLT3/pan-BTK inhibitor. Luxeptinib induces cell cycle blocking, apoptosis, or autophagy in acute myeloid leukemia.
Casnumber
1616428-23-9
Formula
C25H17F4N5O2
Mw
495.43
Psmiles
CC1=CN=C(N1)C2=C3C(=C(C=C2)C4=C(C=C(C=C4)NC(=O)NC5=C(C=C(C=C5F)F)F)F)CNC3=O
Purity
>99%
Solubility
DMSO ≥ 60 mg/mL
Target synonyms
CG-806
Technical documents

Documents

Coa

A PARTNER IN YOUR RESEARCH

More time for discovery. Less time sourcing.

Bring your laboratory requirements together with scientific advice, global sourcing and dedicated procurement support.

Explore our services

Starting a new laboratory?

Plan your laboratory with our New-Lab programme.

Discover New-Lab